Please login to the form below

Not currently logged in
Email:
Password:

W2O bolsters its commercialisation offering

Rita Glaze joins the firm as leader of value, pricing and market access practice

Rita GlazeW2O, an independent network of analytics, marketing and communications firms, has appointed Rita Glaze as its new practice leader of value, pricing and market access.

The new role aims to strengthen the group’s healthcare commercialisation offering and together with the practice’s founder Brian Reid, Glaze will build a multi-dimensional team to help clients with pricing and reimbursement strategy and communications.

She said: “I am thrilled to have joined W2O and look forward to working with Brian and the team to build this practice.

“We have the opportunity, through an analytics-driven approach, to work closely with pharmaceutical and biotech companies to align commercial objectives with the pricing and value realities within their markets.”

Glaze has 25 years’ experience in the biopharmaceutical and life science sector with expertise in marketing, managed markets, pricing strategy and communications.

She has held senior positions with organisations such as Takeda, Allscripts, Searle/Pharmacia.

Joining the network from Edelman, Glaze previously led the design and implementation of its US market access communications offering.

8th February 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics